Literature DB >> 8397561

Fetal cardiac size in normal, intrauterine growth retarded, and diabetic pregnancies.

J C Veille1, R Hanson, M Sivakoff, H Hoen, M Ben-Ami.   

Abstract

A total of 177 M-mode echocardiography studies were done on three groups of fetuses at different gestational ages: group I, normally grown fetuses; group II, intrauterine growth-retarded fetuses (IUGR); and group III, fetuses of diabetic mothers. Adjusted for gestational age and for fetal weight, the hearts of fetuses with IUGR were found to have an increased minor axis dimension due to free wall hypertrophy. No ventricular dilation was found in this group. Furthermore, IUGR fetuses have a larger heart proportionally to their body weight, raising the possibility of a "sparing effect" in this particular group. The hearts of fetuses of diabetic mothers were also found to have a significantly larger cardiac size than that of a group of normally grown fetuses. The increase was secondary to free wall hypertrophy, interventricular septal hypertrophy, and right ventricular dilation. This study confirms previous reports about fetal diabetic cardiomegaly and documents the contribution of the different cardiac components to this increase in size. The free wall hypertrophy found in these two groups may occur by different processes, which needs to be further investigated.

Entities:  

Mesh:

Year:  1993        PMID: 8397561     DOI: 10.1055/s-2007-994739

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  20 in total

Review 1.  Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function.

Authors:  Joana O Miranda; Carla Ramalho; Tiago Henriques-Coelho; José Carlos Areias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Assessment of the Fetal Myocardial Performance Index in Well-Controlled Gestational Diabetics and to Determine Whether It Is Predictive of Adverse Perinatal Outcome.

Authors:  Ismail Bhorat; Morgan Pillay; Tarylee Reddy
Journal:  Pediatr Cardiol       Date:  2019-07-19       Impact factor: 1.655

3.  Maternal diabetes and the fetal heart.

Authors:  L K Hornberger
Journal:  Heart       Date:  2006-05-12       Impact factor: 5.994

4.  The fetal cardiovascular response to increased placental vascular impedance to flow determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis.

Authors:  Neil Hamill; Roberto Romero; Sonia Hassan; Wesley Lee; Stephen A Myers; Pooja Mittal; Juan Pedro Kusanovic; Mamtha Balasubramaniam; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Jimmy Espinoza; Francesca Gotsch; Luis F Goncalves; Shali Mazaki-Tovi; Offer Erez; Edgar Hernandez-Andrade; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2012-12-07       Impact factor: 8.661

5.  Cardiac vectors in the healthy human fetus: developmental changes assessed by magnetocardiography and realistic approximations of the volume conductor.

Authors:  R Tao; E A Popescu; W B Drake; M Popescu
Journal:  Physiol Meas       Date:  2013-04-22       Impact factor: 2.833

Review 6.  Learn from Your Elders: Developmental Biology Lessons to Guide Maturation of Stem Cell-Derived Cardiomyocytes.

Authors:  Silvia Marchianò; Alessandro Bertero; Charles E Murry
Journal:  Pediatr Cardiol       Date:  2019-08-06       Impact factor: 1.655

Review 7.  The fetal brain sparing response to hypoxia: physiological mechanisms.

Authors:  Dino A Giussani
Journal:  J Physiol       Date:  2016-01-06       Impact factor: 5.182

8.  Exposure to Δ9-tetrahydrocannabinol during rat pregnancy leads to impaired cardiac dysfunction in postnatal life.

Authors:  Kendrick Lee; Steven R Laviolette; Daniel B Hardy
Journal:  Pediatr Res       Date:  2021-04-20       Impact factor: 3.756

9.  Systemic maternal inflammation and neonatal hyperoxia induces remodeling and left ventricular dysfunction in mice.

Authors:  Markus Velten; Kirk R Hutchinson; Matthew W Gorr; Loren E Wold; Pamela A Lucchesi; Lynette K Rogers
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

Review 10.  The highs and lows of programmed cardiovascular disease by developmental hypoxia: studies in the chicken embryo.

Authors:  N Itani; C E Salinas; M Villena; K L Skeffington; C Beck; E Villamor; C E Blanco; D A Giussani
Journal:  J Physiol       Date:  2017-11-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.